Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Analgesics
Research results from National Institutes of Health update understanding of flu vaccines
May 18th, 2008
According to recent research published in the journal Vaccine, "Avian-to-human transmission of the high pathogenicity (HP) H7N7 subtype avian influenza viruses in the Netherlands during 2003 caused zoonotic infections in 89 people, including a case of acute fatal respiratory distress syndrome. Public health emergency preparedness against H7N7 avian influenza viruses with pandemic potential. includes the development of vaccine candidate viruses." "In order to develop a high growth reassortant vaccine candidate virus, tow pathogenicity (LP) A/mallard/Netherlands/12/2000 (H7N3) and A/mattard/Netherlands/2/2000 (H10N7) strains were selected as donors of the H7...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
